Other preventative measures include management of comorbidities such as obesity and treatment of sleep apnoea.36 Future studies on the contribution of TMPRSS2 triplication and developing therapies that may be particularly relevant to DS are needed. The gene discussed is TMPRSS2; the disease is obesity due to melanocortin 4 receptor deficiency.